Related Experiment Video
Updated: May 9, 2026

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
Published on: May 11, 2018
Ventricular assist device for failing systemic ventricle in an adult with prior mustard procedure
Robert C Neely1, Robert Patrick Davis, Elizabeth H Stephens
1Division of Cardiothoracic Surgery, Department of Surgery, Columbia University Medical Center, New York, New York 48824-1317, USA. rcn2101@columbia.edu
Abstract:
The Mustard procedure is a palliative surgical procedure used to repair complete transposition of the great arteries. Cardiac transplantation remains the only definitive therapy for patients who develop heart failure after a Mustard procedure. However, pulmonary hypertension represents a major hemodynamic contraindication. The use of a ventricular assist device as destination therapy has not yet been established after a Mustard procedure. Here, we present the case of a 41-year-old patient who presented with systemic right ventricular failure following Mustard procedure complicated by pulmonary hypertension. The patient received a HeartMate II (Thoratec, Pleasanton, CA) ventricular assist device as a bridge to decision.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
